Log in to save to my catalogue

Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives

Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e214535bf2014c6990306c81a86641dc

Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives

About this item

Full title

Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Drug design, development and therapy, 2020-01, Vol.14, p.5375-5392

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Platinum (Pt)-based anticancer drugs such as cisplatin have been used to treat various cancers. However, they have some limitations including poor selectivity and toxicity towards normal cells and increasing chemoresistance. Therefore, there is a need for novel metallo-anticancers, which has not been met for decades. Since the initial introduction...

Alternative Titles

Full title

Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e214535bf2014c6990306c81a86641dc

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e214535bf2014c6990306c81a86641dc

Other Identifiers

ISSN

1177-8881

E-ISSN

1177-8881

DOI

10.2147/DDDT.S275007

How to access this item